APA (7th ed.) Citation

Cadavid, D., Jurgensen, S., & Lee, S. (2013). Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis. PloS one, 8(1), e53297. https://doi.org/10.1371/journal.pone.0053297

Chicago Style (17th ed.) Citation

Cadavid, Diego, Stephanie Jurgensen, and Sophia Lee. "Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis." PloS One 8, no. 1 (2013): e53297. https://doi.org/10.1371/journal.pone.0053297.

MLA (9th ed.) Citation

Cadavid, Diego, et al. "Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis." PloS One, vol. 8, no. 1, 2013, p. e53297, https://doi.org/10.1371/journal.pone.0053297.